2019
DOI: 10.1111/lam.13240
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of MASTDISCS combi Carba plus for the identification of metallo‐β‐lactamases, KPC and OXA‐48 carbapenemase genes in Enterobacteriaceae clinical isolates

Abstract: The increasing frequency of class A KPC enzymes, class B metallo‐β‐lactamases (MBLs) and class D OXA‐48 enzymes in Enterobacteriaceae makes their early identification urgent. A simple commercial MASTDISCS combi Carba plus disc system (MAST‐Carba plus) was designed for the identification of MBLs, KPC and OXA‐48 carbapenemase genes in Enterobacteriaceae. To validate the MAST‐Carba plus, a total of 77 isolates of carbapenemase‐producing Enterobacteriaceae (CPE) and 84 isolates of noncarbapenemase‐producing Entero… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(23 citation statements)
references
References 17 publications
0
22
1
Order By: Relevance
“…In the current study, the following antimicrobials were tested: piperacillin and piperacillin-tazobactam (β-lactams and β-lactamase-inhibitor combination); ceftazidime, ceftriaxone, cefazoline, cefepime and cefoxitin (cephalosporins); gentamicin and amikacin (aminoglycosides); imipenem, ertapenem and meropenem (carbapenems); ciprofloxacin (quinolone); trimethoprim/sulphamethoxazole (sulphonamide); tigecycline (tetracycline); and nitrofurantoin (in urinary infection). They were determined for all these isolates using the Vitek-2 automated (GN-20 and 22 AST card) system (bioMerieux, USA) according to the manufacturer’s instructions [ 10 ]. The resistance profiles were categorised into MDR, XDR and PDR according to Algammal [ 1 ].…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…In the current study, the following antimicrobials were tested: piperacillin and piperacillin-tazobactam (β-lactams and β-lactamase-inhibitor combination); ceftazidime, ceftriaxone, cefazoline, cefepime and cefoxitin (cephalosporins); gentamicin and amikacin (aminoglycosides); imipenem, ertapenem and meropenem (carbapenems); ciprofloxacin (quinolone); trimethoprim/sulphamethoxazole (sulphonamide); tigecycline (tetracycline); and nitrofurantoin (in urinary infection). They were determined for all these isolates using the Vitek-2 automated (GN-20 and 22 AST card) system (bioMerieux, USA) according to the manufacturer’s instructions [ 10 ]. The resistance profiles were categorised into MDR, XDR and PDR according to Algammal [ 1 ].…”
Section: Methodsmentioning
confidence: 99%
“…Carbapenemase production was examined phenotypically for all strains that showed resistance or intermediate resistance to carbapenem drugs, or demonstrated resistance to either third-generation cephalosporins or cefoxitin, using the MASTDISCS® Combi Carba plus (Carba plus) commercial combination disc assay, according to the manufacturer’s instructions [ 10 , 21 ].…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…When both Discs C and D show zone differences of 5mm or more compared with Disc A, AmpC production is indicated. OXA-48 production is indicated when an inhibition zone diameter of 10mm or less around Disc E as the high-level resistance to Temocillin is characteristic of OXA-48 [10]. Quality control of the culture media, Gram stain, and antimicrobial sensitivity tests was checked using standardized reference strains of E. coli (ATCC 25922), S. aureus (ATCC 25923) and P. aeruginosa ATCC 27853 [9].…”
Section:  Antimicrobial Testingmentioning
confidence: 99%